$COCO

Liran Ira sold $7.6M of COCO

Liran Ira sold 95,768 shares of Vita Coco Company, Inc. (COCO) at $79.14 ($7.58M total) on 2026-06-11 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Liran Ira
Published Jun 12, 2026, 8:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 12, 2026, 8:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$COCO
Neutral
medium confidence
Mentioned
$COCO
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$COCONeutralLow
01

Why it matters

The disclosure updates the insider ownership record and may influence short-term sentiment, but it does not introduce new fundamentals (no guidance, contracts, litigation, or operational updates).

02

Market read

Traders may monitor whether additional planned sales occur, but the 10b5-1 structure makes this more of a disclosure than a catalyst.

03

What to watch

The article provides only the sale details; it does not state whether there were concurrent buys, changes in total insider holdings beyond the post-transaction figure, or any broader company developments.

Relevance 5/10Novelty 8/10Timing: Filed June 12; sale executed June 11

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for Vita Coco Company, Inc.

Company-level read

Ticker impact

$COCONeutralMedium confidence
Context

SEC Form 4 shows director Liran Ira sold 95,768 shares in an open-market transaction worth about $7.58M on June 11 under a 10b5-1 plan.

Expected impact

Likely limited near-term impact; any effect would be sentiment/positioning rather than a fundamental catalyst.

Evidence & confidence

The filing is primary-source and time-stamped, but it is an automated/plan-based sale with no accompanying company-specific operational or financial news.

Market effects

No clear sector read-through; this is a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated sizable sales can still be interpreted by some traders as confidence erosion, especially if paired with other negative signals not mentioned here.

Key entities

  • Vita Coco Company, Inc.

    COCO, subject of the Form 4 insider sale disclosure.

  • Liran Ira

    Director who sold 95,768 shares under a pre-arranged Rule 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$COCOMed

Piper Sandler raises Vita Coco stock price target on earnings beat

Piper Sandler raised its price target for The Vita Coco Co. (NASDAQ:COCO) to $88 from $83, citing strong Q3 2026 results. The company reported 26.1% revenue growth and raised its sales guidance. Piper Sandler also increased its 2026 and 2027 EBITDA estimates. Vita Coco plans pricing increases to offset costs. The stock is trading at a low P/E ratio relative to earnings growth, with a PEG ratio of 0.45. Evercore ISI reiterated its Outperform rating with a $80 price target.

$COCOMedAI 8/10

Evercore ISI reiterates Vita Coco stock rating on demand strength

Evercore ISI reiterated an Outperform rating and $80 price target for The Vita Coco Co. Inc (COCO) after its Q3 results. The company beat expectations with $244M in net sales and $0.58 EPS, but shares fell 5% due to margin concerns. COCO's market cap is $3.63B, with shares down from a 52-week high of $85.83. Management expects low 20s% growth in 2026, up from prior forecasts. Supply chain issues have caused inventory shortages, but the company expects improvements in Q4 2026.

$COCOHighAI 8/10

The Vita Coco Co Inc (COCO) (Q3 2026) Earnings Call Highlights: Net Sales Surge 34%

The Vita Coco Co Inc (COCO) reported Q3 2026 net sales up 34% YoY to $244M, driven by strong coconut water and private label growth. International sales surged 48%. Full-year guidance was raised, but supply chain issues and cost pressures weighed on margins. Management expects capacity constraints to persist into early 2027 and deferred pricing to impact margins until then.

$COCOMed

Vita Coco (COCO) Q3 2026 Earnings Call Transcript

Vita Coco (COCO) reported Q3 2026 net sales up 34%, with coconut water and private label growth of 15% and 152% respectively. U.S. retail dollar sales grew 28%, while European markets saw 66% growth. The company plans to launch new products and expand supply chain capacity. Inflationary pressures impacted gross margins, with pricing adjustments expected in 2027.